Advancis Pharmaceutical Corp. reported net loss for the first quarter at $7.6 million, narrower than $11.4 million in the year-ago quarter. On a per share basis, loss for the current quarter narrowed to $0.25 from $0.50 in the same quarter last year. Analysts polled by First Call/Thomson Financial expected a loss of $0.29 per share. Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/241716/)